Sysmex Corporation (TYO:6869)

Market Cap	1.52T
Revenue (ttm)	508.64B
Net Income (ttm)	53.67B
Shares Out	619.07M
EPS (ttm)	86.05
PE Ratio	28.61
Forward PE	25.35
Dividend	36.00 (1.45%)
Ex-Dividend Date	Mar 28, 2025

Volume	1,274,800
Average Volume	1,655,935
Open	2,460.50
Previous Close	2,478.50
Day's Range	2,446.50 - 2,473.50
52-Week Range	2,138.00 - 3,236.00
Beta	0.81
RSI	48.74
Earnings Date	Aug 6, 2025

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers;...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1968
• Employees: 10,042
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6869

Financial Performance

In 2024, Sysmex's revenue was 508.64 billion, an increase of 10.21% compared to the previous year's 461.51 billion. Earnings were 53.67 billion, an increase of 8.12%.